Opioid Induced Constipation Treatment Market to Register Substantial Expansion by 2023
In a highly consolidated Opioid Induced Constipation Treatment Market, the top three companies, namely Takeda, Boehringer Ingelheim, and Valeant Pharmaceuticals International Ltd collectively held 91.8% in the overall market in 2014. However, Takeda Pharmaceuticals Company Ltd enjoys clear dominance because of popularity of its approved drug Amitiza.
View full press release